ArticleOncoTargets and therapy2015

Protein tyrosine phosphatase SHP-1 sensitizes EGFR/HER-2 positive breast cancer cells to trastuzumab through modulating phosphorylation of EGFR and HER-2.

Yifen Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.